China Regenerative Medicine International (HKSE:08158) EBIT per Share : HK$-0.41 (TTM As of Jun. 2024)

View and export this data going back to 2001. Start your Free Trial

What is China Regenerative Medicine International EBIT per Share?

China Regenerative Medicine International's EBIT per Share for the three months ended in Jun. 2024 was HK$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.41.

During the past 12 months, the average EBIT per Share Growth Rate of China Regenerative Medicine International was -327.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was 27.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for China Regenerative Medicine International's EBIT per Share or its related term are showing as below:

HKSE:08158' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -36 Med: -5.1 Max: 55.9
Current: 27

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of China Regenerative Medicine International was 55.90% per year. The lowest was -36.00% per year. And the median was -5.10% per year.

HKSE:08158's 3-Year EBIT Growth Rate is ranked better than
71.93% of 1236 companies
in the Biotechnology industry
Industry Median: 8.1 vs HKSE:08158: 27.00

China Regenerative Medicine International's EBIT for the three months ended in Jun. 2024 was HK$0.00 Mil.

China Regenerative Medicine International EBIT per Share Historical Data

The historical data trend for China Regenerative Medicine International's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Regenerative Medicine International EBIT per Share Chart

China Regenerative Medicine International Annual Data

Trend

Apr15

Apr16

Apr17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.77

0.23

0.03

-0.37

0.06

China Regenerative Medicine International Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial															0.03	-0.02	-0.39	-	-

China Regenerative Medicine International EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

China Regenerative Medicine International's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-106.72	/	286.409
=	-0.37

China Regenerative Medicine International's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0	/	304.252
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-0.41

China Regenerative Medicine International (HKSE:08158) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

China Regenerative Medicine International EBIT per Share Related Terms

Thank you for viewing the detailed overview of China Regenerative Medicine International's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

China Regenerative Medicine International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Regenerative Medicine International Ltd (HKSE:08158) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

132 Nathan Road, Suite 2310-18, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG

Website

https://www.crmi.hk

China Regenerative Medicine International Ltd is an investment holding company engaged in the provision of healthcare products and services. Its reportable segments are Aesthetic medical and beauty services and Medical services. The vast majority of the company's revenue is derived from its Aesthetic medical and beauty services segment. Geographically, the People's Republic of China accounts for the majority of the revenue. It also has a presence in Hong Kong.

Executives

Central Huijin Investment Ltd.	2201 Interest of corporation controlled by you
Wang Chuang	2101 Beneficial owner
Arab Osman Mohammed	2501 Other
Wong Kwok Keung	2501 Other
Lei Changjuan	2101 Beneficial owner
Chang Zhou Shi Zhong Min Xing Kong Qi Ye Guan Li Zi Xun Fu Wu He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Kong Yudong	2101 Beneficial owner
Chang Zhou Shi Yao Guang Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Li Ren	2201 Interest of corporation controlled by you
Nat-ace Wood Industry Ltd. (formerly Known As Forerunner Technology Limited)	2201 Interest of corporation controlled by you
All Favour Holdings Limited	2101 Beneficial owner
Deng Shufen	2202 Interest of your spouse
Dai Yumin	2201 Interest of corporation controlled by you
Wang Xiaogang	2101 Beneficial owner
China Orient Asset Management Co., Ltd.	2106 Person having a security interest in shares

China Regenerative Medicine International Headlines

No Headlines